|
[1]
|
刘世华, 马乐龙, 印爱珍, 等. 多学科协作在儿童多重耐药菌医院感染防控中的应用[J]. 中国感染控制杂志, 2021, 20(6): 550-556.
|
|
[2]
|
Meropol, S.B., Haupt, A.A. and Debanne, S.M. (2017) Incidence and Outcomes of Infections Caused by Multidrug-Resistant Enterobacteriaceae in Children, 2007-2015. Journal of the Pediatric Infectious Diseases Society, 7, 36-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
El-Nawawy, A., Ashraf, G.A., Antonios, M.A.M., Meheissen, M.A. and El-Alfy, M.M.R. (2018) Incidence of Multidrug-Resistant Organism among Children Admitted to Pediatric Intensive Care Unit in a Developing Country. Microbial Drug Resistance, 24, 1198-1206. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Mahony, M., McMullan, B., Brown, J. and Kennedy, S.E. (2019) Multidrug-resistant Organisms in Urinary Tract Infections in Children. Pediatric Nephrology, 35, 1563-1573. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Flannery, D.D., Chiotos, K., Gerber, J.S. and Puopolo, K.M. (2021) Neonatal Multidrug-Resistant Gram-Negative Infection: Epidemiology, Mechanisms of Resistance, and Management. Pediatric Research, 91, 380-391. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
杨昊, 刘长秀, 李童. 2018-2020年岳阳市儿童常见多重耐药菌感染及耐药性分析[J]. 甘肃医药, 2023, 42(10): 897-899.
|
|
[7]
|
吕婧雯, 田本顺, 银晓聪, 等. 2012-2020年广州地区肺炎链球菌耐药趋势增高及聚集性多重耐药模式[J]. 南京医科大学学报(自然科学版), 2022, 42(6): 854-860.
|
|
[8]
|
刘艳, 马丹娟, 黄瑞玉, 等. 新生儿重症监护病房多重耐药革兰阴性菌血流感染危险因素回归分析[J]. 检验医学与临床, 2019, 16(6): 783-785.
|
|
[9]
|
Newman, A.M. and Arshad, M. (2020) The Role of Probiotics, Prebiotics and Synbiotics in Combating Multidrug-Resistant Organisms. Clinical Therapeutics, 42, 1637-1648. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Hsu, A.J. and Tamma, P.D. (2014) Treatment of Multidrug-Resistant Gram-Negative Infections in Children. Clinical Infectious Diseases, 58, 1439-1448. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
卫生部办公厅. 卫生部办公厅关于印发《多重耐药菌医院感染预防与控制技术指南(试行)》的通知[J]. 中华人民共和国卫生部公报, 2011(2): 59-61.
|
|
[12]
|
江梅, 黎毅敏, 郑劲平. GRADE方法在呼吸机相关性肺炎诊断、预防和治疗指南制定中的应用[J]. 中国循证医学杂志, 2014, 14(7): 897-900.
|
|
[13]
|
血管导管相关感染预防与控制指南(2021版) [J]. 中国感染控制杂志, 2021, 20(4): 387-388.
|
|
[14]
|
中华人民共和国卫生部. 医院感染诊断标准(试行) [J]. 中华医学杂志, 2001, 81(5): 314-320.
|
|
[15]
|
卫生部北京医院. 全国临床检验操作规程[Z]. 1999.
|
|
[16]
|
Rodriguez, B.A., Girotto, J.E. and Nicolau, D.P. (2018) Ceftazidime/avibactam and Ceftolozane/Tazobactam: Novel Therapy for Multidrug Resistant Gram Negative Infections in Children. Current Pediatric Reviews, 14, 97-109. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Gargiullo, L., Del Chierico, F., D’Argenio, P. and Putignani, L. (2019) Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives. Frontiers in Microbiology, 10, Article 1704. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Williams, P.C. (2020) Potential of Fosfomycin in Treating Multidrug‐Resistant Infections in Children. Journal of Paediatrics and Child Health, 56, 864-872. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
谢朝云, 熊芸, 覃家露, 等. 儿童细菌性重症肺炎多重耐药菌感染相关因素分析[J]. 中国儿童保健杂志, 2018, 26(3): 325-328.
|
|
[20]
|
李敏敏, 邝舒敏, 黄冬平, 等. 儿童重症监护室多重耐药菌主动筛查分布分析[J]. 广东医学, 2020, 41(24): 2559-2563.
|
|
[21]
|
雷宏莹, 吴玮哲. 临床药师参与经口咽齿状突切除术后多重耐药铜绿假单胞菌感染儿童会诊1例[J]. 中国医药科学, 2023, 13(14): 191-194.
|
|
[22]
|
谢朝云, 蒙桂鸾, 李耀福, 等. 新生儿败血症死亡与多重耐药菌感染相关性的回顾性巢式病例对照研究[J]. 西北国防医学杂志, 2020, 41(2): 103-108.
|
|
[23]
|
卢蔚薇, 赖宇涛, 童雅婵, 等. 新生儿重症监护病房多重耐药菌反复感染的危险因素分析[J]. 传染病信息, 2023, 36(3): 243-247.
|
|
[24]
|
许丽君. 新生儿重症监护病房多重耐药菌感染情况及其血流感染的危险因素分析[J]. 中外医学研究, 2023, 21(25): 86-91.
|
|
[25]
|
刘巍巍, 焦颖, 张巍, 等. 重症监护室新生儿鲍曼不动杆菌侵袭性感染临床特征及药敏分析[J]. 中国临床医生杂志, 2019, 47(8): 975-978.
|
|
[26]
|
Cies, J.J., Palladino, C., Mahmood, H., Moore, W.S. and Chopra, A. (2020) Targeted Multidrug Resistant Organism Antimicrobial Prophylaxis and Postoperative Infections in Pediatric Cardiothoracic Surgical Patients. Pediatric Infectious Disease Journal, 39, 514-518. [Google Scholar] [CrossRef] [PubMed]
|